One novel research study has shown that venom from a honeybee can target human cells of aggressive breast cancer and, consequently, may be used to treat cancer in a new way. The study that was carried out by the scientists of the Harry Perkins Institute of Medical Research in Australia emphasizes the considerable anti-cancer activity of the key ingredient in bee venom called melittin.
How Honeybee Venom Targets Cancer Cells
The research that was reported in the publication Nature Precision Oncology revealed that melittin, an element of honeybee venom, can instantly annihilate the triple-negative breast cancer cells, which are the most aggressive and the hardest forms of breast cancer. The triple-negative breast cancer is a type of cancer without targeted therapies.
They approved their concept by trying the venom of over 300 honeybees and bumblebees. Moreover, they concluded that melittin kills not only cancer cells but also does it without injuring healthy cells. The action of the compound consists of the destruction of the cancer cells’ outer membranes, thus it can be the process of their death.
A Potential Breakthrough in Cancer Treatment
Dr. Ciara Duffy, the chief scientist, has stated that melittin can be applied along with the chemotherapy drugs that are available in the market, thus, it will be more effective. In experiments on animals, the venom was capital of drastically reducing tumor growth even within twenty minutes.
It was understood by the researchers that melittin disturbs the signaling ways of the cancer cells and thus it theoretically forbids their growth and multiplication. This double-function phenomenon makes it a good candidate for the next cancer therapies.
Future Implications and Next Steps
Although the outcomes are good, there is a need for further investigation to ascertain how to use melittin in a safe and effective manner for human therapies. The scientists are searching for means to mimic the substance artificially so that it will be unnecessary to get the bee venom by extraction from live bees.
This investigation provides an opportunity to explore the nature-based anticancer therapies that are new and innovative, deeply confirming the significance of the bee populations, which are the principal actors in ecosystems and the sources of medical research.
Conclusion
The finding that bee venom kills those breast cancer cells, which are highly aggressive, is indeed a breakthrough in oncology. The melittin may turn out to be the crucial weapon in the battle against triple-negative breast cancer, together with other difficult-to-cure tumors, if the research sustains the current pace.
